Steve Sadoff, CEO, CannaGlobal Wellness
We spoke to Steve Sadoff, CEO of newly-formed CannaGlobal Wellness, about his plans in the psychedelic space.
Continue Reading
Steve Sadoff, CEO, CannaGlobal Wellness
Spencer Hawkswell, TheraPsil
We spoke to Spencer Hawkswell, Executive Director of TheraPsil: a non-profit advocacy group seeking to facilitate legal access to psilocybin therapy for terminally-ill patients.
Continue Reading
Spencer Hawkswell, TheraPsil
JR Rahn, MindMed
We spoke to JR Rahn, Co-Founder, Director & Co-CEO of MindMed. We asked JR about his Company's clinical trials, how COVID-19 has affected their operations, and their plans for the…
Continue Reading
JR Rahn, MindMed
Alex Speiser, Orthogonal Thinker
We spoke to Alex Speiser, COO of Orthogonal Thinker: a Company with holdings including psychedelic science business Ei.Ventures. Having already raised $6m, Orthogonal is now fundraising once more to move…
Continue Reading
Alex Speiser, Orthogonal Thinker
Interview with GreenStar Biosciences and Eleusian Biosciences, Following Acquisition Announcement
Yesterday, GreenStar Biosciences announced their signing of a letter of intent to acquire Eleusian Biosciences, a Toronto-based company focused on the development of medical devices and therapeutics. Eleusian has filed…
Continue Reading
Interview with GreenStar Biosciences and Eleusian Biosciences, Following Acquisition Announcement
Ashley Lukens, Ei Foundation
As our readers know, Psilocybin Alpha is primarily geared towards providing resources to those looking to invest in the emergent psychedelic sector. This interview is a slight detour from the…
Continue Reading
Ashley Lukens, Ei Foundation
Interview with Shlomi Raz, CEO and Chairman of Eleusis
Eleusis was founded in 2013, and claims to be the first company in the world dedicated to transforming psychedelics into medicines.We spoke to Shlomi Raz, CEO and Chairman of the…
Continue Reading
Interview with Shlomi Raz, CEO and Chairman of Eleusis
Interview with Timothy Ko, CEO, Entheon
Having just closed a successful raise, we spoke to Timothy Ko about Entheon's plans for the near future, and the challenges his team may face. PA: What's your personal story…
Continue Reading
Interview with Timothy Ko, CEO, Entheon
Interview with Dr. Evan Wood, CMO at Numinus
Yesterday, Dr. Evan Wood was appointed as Chief Medical Officer of Numinus (TSXV:NUMI). Dr. Wood has an extensive bibliography of published research and has held a suite of positions across…
Continue Reading
Interview with Dr. Evan Wood, CMO at Numinus
Interview with Dr. Roger McIntyre, CEO of Champignon Brands
Earlier this week, Dr. Roger McIntyre was appointed as CEO of Champignon Brands. We spoke with McIntyre about his immediate and future plans for the company... PA: You were recently…
Continue Reading
Interview with Dr. Roger McIntyre, CEO of Champignon Brands
